SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " j.p. morgan " 32 found 🔀 AI-powered Shuffle
JPMorgan and Hyundai Group test AI agents for business payments
Umar Farooq, Global Co-Head at J.P. Morgan Payments, says a new proof of concept with Hyundai Group will test AI agents moving money between businesses. He describes it as part of a global, multi-currency platform with steadily growing volumes.
DTE Energy selling Vantage business for $3 billion to focus on electric, gas utility growth
The Detroit-based company announced it reached an agreement to sell nearly all of DTE Vantage, except EES Coke, to institutional investors advised by J.P. Morgan Asset Management’s Global Infrastructure group.
Think Your Business Is Ready to Sell? J.P. Morgan Says These 2 Problems Are Killing Deals
Inc. sat down with the head of JPMorgan's new banking team to see what it's looking for in the current tough deal environment.
Emotional intelligence is the edge in an AI-fueled world, J.P. Morgan’s behavioral science head says
J.P. Morgan's Jeff Kreisler told DC West 2026 that emotional intelligence — empathy, trust-building and intrinsic motivation — is the advantage AI cannot replicate for financial professionals.
Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
o2h co-discovery has announced that the Cambridge × London Life Sciences Showcase will return for its second edition during J.P. Morgan Healthcare Week 2027 in San Francisco.
JPMorgan Weighs Opening Card Business to Private Credit
J.P. Morgan Chase is reportedly exploring whether other funding sources could approve some of the cards it rejects. That's according to a report late
Wall Street Bets: DraftKings, Penn Entertainment, Inspired Entertainment, New York online sports betting
J.P. Morgan’s Dan Politzer examined the recent DraftKings’ earnings call on August 7: “DraftKings’ report itself was better than feared, as 2Q Adjusted EBITDA o
Rollins College of Business Alumni Spotlight: Benjamin Cheatham on His Path from UTC to J.P. Morgan - Gary W. Rollins College of Business
UTC accounting and finance alumnus Benjamin Cheatham launched a successful career at after graduating from the Rollins College of Business.
Adient plc (ADNT) Releases China Business Update
Adient plc (NYSE:ADNT) is one of the Best Undervalued Stocks to Buy According to the Financial Media. On May 20, the company released its China business update, wherein it highlighted that, since last year’s J.P. Morgan Summit, it has seen robust new bookings that continue to support the sales growth momentum. Adient plc (NYSE:ADNT) won ~$1.1 billion […]
145M-user WEBTOON heads to investor conferences in Boston, Hong Kong, SF
Live webcasts of WEBTOON’s J.P. Morgan and Evercore presentations will stream on its IR site as the 145M-user platform appears at investor events in 3 cities.
WEBTOON Entertainment Inc. to Participate in Upcoming Investor Conferences
LOS ANGELES, May 12, 2026 (GLOBE NEWSWIRE) -- WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytelling platforms, today announced it will participate in the following upcoming investor conferences: J.P. Morgan 2026 Global Technology, Media and Communications ConferenceMay 20, 2026Presentation Time: 10:40 am ETLocation: Boston, MA UBS Asian Investment Conference 2026May 28, 202
Flutter Entertainment Announce Management Participation in Upcoming Event
DUBLIN and TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Flutter Entertainment (“Flutter”) (NYSE:FLUT, LSE:FLTR), the leading online sports betting and iGaming operator, today announced that Peter Jackson, Chief Executive Officer, and Rob Coldrake, Chief Financial Officer, will participate in the following event: J.P. Morgan fireside chat scheduled on Monday, May 11, 2026 at 8:30am EDT / 1:30pm BST The live audio webcast for the J.P. Morgan fireside chat can be accessed via www.flutter.com/investors
Did DOJ Settlement and Strong Ticket Demand Just Shift Live Nation Entertainment's (LYV) Investment Narrative?
Live Nation Entertainment recently outlined continued strong global concert demand, pricing power and a favorable Department of Justice settlement that avoided a Ticketmaster divestiture, while also confirming past management presentations at MoffettNathanson and J.P. Morgan investor conferences, both of which were webcast to investors. These developments, alongside Vanguard holding over 12.04 million shares and modest insider selling, spotlight how regulatory outcomes and investor...
Live Nation Entertainment To Participate In MoffettNathanson's Media, Internet & Communications Conference And J.P. Morgan's 2026 Global Technology, Media And Communications Conference
/PRNewswire/ -- Live Nation Entertainment, Inc. (NYSE: LYV), the world's leading live entertainment company, announced today that management will be presenting...
Live Nation Entertainment To Participate In MoffettNathanson's Media, Internet & Communications Conference And J.P. Morgan's 2026 Global Technology, Media And Communications Conference
Live Nation Entertainment, Inc. (NYSE: LYV), the world's leading live entertainment company, announced today that management will be presenting at MoffettNathanson's Media, Internet & Communications Conference on Thursday, May 14, 2026 at 8:15 a.m. PT, and at J.P. Morgan's 2026 Global Technology, Media and Communications Conference on Wednesday, May 20, 2026 at 7:00 a.m. PT.
Inside Gaming: Strip casino operator unveils more summer deals
Plus, J.P. Morgan analyst Daniel Politzer outlines how a potential sale of Caesars Entertainment could realistically take shape.
J.P. Morgan lifts S&P 500 year-end target to 7,600 on AI-driven earnings
J.P. Morgan on Tuesday raised its year-end target for the S&P 500 index to 7,600, citing AI and tech-driven earnings, just weeks after lowering its forecast, with a ceasefire between the U.S. and Iran aiding sentiment.
J.P. Morgan Sees Resiliency in U.S. Economy Despite Iran War
The nation’s largest bank said it earned record trading profits in the first quarter but tempered expectations overall for its business.
Daniel Miller
Daniel Miller is a reporter at POLITICO covering the intersection of entertainment, media, sports, technology and politics.Part of POLITICO’s California team since 2026, he examines how Hollywood and Southern California function as engines of political power. Daniel also covers the rainmakers, dealmakers and cultural figures who shape policy debates, elections and public life far beyond the state’s borders.Daniel previously spent 13 years at the Los Angeles Times, most recently as an enterprise reporter in the newspaper’s Metro department, where he worked on investigations and features. He wrote about allegations of sexual misconduct at L.A.’s Magic Castle, chronicled the cratering ventures of a celebrity vegan chef and detailed themystery of a missing million-dollar pocket watch once owned by J.P. Morgan. In 2019, he wrote, reported and hosted "Larger Than Life," an award-winning podcast about the life of an enigmatic L.A. street racer.He previously covered the business of entertainment for The Times, examining the fraught political ties between the Walt Disney Co. and the city of Anaheim, probing the world of second-tier talent agents operating on Hollywood’s fringes and uncovering allegations involving several #MeToo figures.Daniel was named Journalist of the Year at the 2015 National Arts & Entertainment Journalism Awards and, a year later, received the L.A. Press Club’s Entertainment Journalist of the Year award. He was also a finalist for the 2016 Loeb Awards for "Selling Stardom," a series on unscrupulous Hollywood operators. His narrative reporting has been honored by organizations including the Society for Features Journalism, the National Association of Black Journalists and the Motor Press Guild.Daniel began his career reporting in Southern California, writing for the Ventura County Star, the Los Angeles Business Journal and the Hollywood Reporter. He attended Beverly Hills High School and UCLA. He lives in Los Angeles.
JPM26: Chugai chases new science and name recognition from US biopharma industry
The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. Morgan Healthcare Conference in San Francisco, they’re working hard to change that while also seeking out new science to bring into their storied drug discovery operation.
A Look At Astrana Health’s Valuation As It Updates Investor Presentation For National Platform Expansion
Astrana Health (ASTH) drew fresh attention after updating its investor presentation at the 44th Annual J.P. Morgan Healthcare Conference, outlining its delegated risk and care delivery model across 16 markets and its evolution into a national platform. See our latest analysis for Astrana Health. The refreshed presentation coincides with a recent 15.55% 1 month share price return. However, the 1 year total shareholder return of a 13.05% decline and 3 year total shareholder return of a 22.73%...
Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation
Raising Fiscal 2026 Outlook: Cardinal Health is increasing expectations for fiscal year 2026 non-GAAP diluted earnings per share (EPS)1 to at least $10.00, from its prior guidance range of $9.65...
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
Exceeded 10,000 patients treated to date with CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy manufacturing facility in the U.S.Profitability expected in 2026, driven by continued CARVYKTI® revenue growth and operating margin expansion Treated first patient with in vivo pipeline candidate in investigator-initiated trial Preclinical data from primates provided early validat
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings Call Improves 2025 expected GAAP operating expenses by $200 million since 3Q25 Earnings Call Increases 2025 projected year-end ...
Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
– Reports $156 to $160 Million in Preliminary* Full-Year 2025 U.S. Net Product Sales, a 35% to 38% Increase Compared With Full-Year 2024 – –Total Preliminary* Revenue of $400 to $408 million, a 20% to 23% Increase Compared With Full-Year 2024, and ~55% to 59% Increase Excluding One-Time Milestones – – Cash and Cash Equivalents of Approximately $168 Million* at Year-End 2025 – – Q4 Retail Prescription Equivalents Grew 34% Y/Y and 11.3% Q/Q – – Expects Operating Expenses of Between $210 Million an
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 12-week data from Phase 1 trial of MBX 4291, a dual GLP-1/GIP co-agonist prodrug with potential for once-monthly dosing and improved tolerability for obesity, anticipated in Q4 2026 Nomination of two additional obesity candidates expected in 2026: an amycretin prodrug and a GLP-1/GIP/GCGR triple agonist,
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of key...
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
— BRINSUPRI® (brensocatib) Unaudited Total Revenues of Approximately $144.6 Million for First Full Quarter of Launch; Approximately $172.7 Million for Full-Year 2025— —ARIKAYCE® (amikacin...
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
— BRINSUPRI® (brensocatib) Unaudited Total Revenues of Approximately $144.6 Million for First Full Quarter of Launch; Approximately $172.7 Million for...
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th…...
How much the bankers are getting paid in the Warner Bros. Discovery deal
Warner Bros. Discovery's sale could rake $225 million in fees for Allen & Co., J.P. Morgan, and Evercore.